| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |